谷歌浏览器插件
订阅小程序
在清言上使用

235MO Efficacy and Safety of Ribociclib (RIB) + Nonsteroidal Aromatase Inhibitor (NSAI) in Younger Patients (pts) with HR+/HER2− Early Breast Cancer (EBC) in NATALEE

S. Loi,E. Stringer-reasor, J-S. Frenel,M. Reinisch,R. ORegan,M. De Laurentiis, Y.H. Park, A. O'Dea,Y-S. Lu, V. Gonzalez, M. Gao, S. Waters, H. Hu, B. Xu

Annals of Oncology(2024)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要